SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Clinical Trial · Recruiting

    Testing the Effects of Cann’App, a Digital Intervention for Cannabis Harm Reduction

    Abstract

    The goal of this clinical trial is to learn if a digital web application can prevent the risks related to cannabis use among adult regular cannabis users who are enrolled in a pilot trial for cannabis sales regulation conducted in Lausanne, Switzerland (i.e., Cann-L study) and have agreed that their data were used in other studies.

    The main question it aims to answer is:

    Do participants who have access to the intervention modules of the web application raise their use of protective behavioral strategies to lower cannabis-related risks?

    Researchers will compare the intervention modules to a control module (i.e., information on cannabis-related risks and harm reduction) to see if the web application works to prevent the risks related to cannabis use. They will also compare intervention modules across each other to see whether one works better than another.

    Participants will:

    * Create a user account in the web application
    * Access the web application using a laptop, tablet or smartphone
    * Use the web application as they wish throughout the duration of the study
    * Complete the regular Cann-L study questionnaires every six months, which will be used to measure their cannabis use and related risks.

    Methodology

    Sample sizen = 565

    Citation

    Free Weekly Briefing

    Cannabis news, every Monday morning.

    Industry intelligence for cannabis operators, regulators, clinicians, and investors — sent every Monday.